The bcl-2/IgH rearrangement in a population of 204 healthy individuals: Occurrence, age and gender distribution, breakpoints, and detection method validity-Reference-Cited by-同舟云学术

The bcl-2/IgH rearrangement in a population of 204 healthy individuals: Occurrence, age and gender distribution, breakpoints, and detection method validity

Published:2006-06 Issue:6 Volume:30 Page:745-750
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Schmitt Christina,Balogh Brigitta,Grundt Alexander,Buchholtz Christian,Leo Albrecht,Benner Axel,Hensel Manfred,Ho Anthony D.,Leo Eugen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference13 articles.

1. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma;Summers;J Clin Oncol,2001

2. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment;Gribben;Blood,1991

3. Interzol (South-East Netherlands Comprehensive Cancer Centers Cooperative Group). Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma;Mandigers;Blood,2001

4. Chromosomal translocation t(14;18) in healthy individuals;Schuler;Semin Cancer Biol,2003

5. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation;Biagi;Blood,2002

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Updates on Diagnosis and Treatment of Follicular Lymphoma;The Korean Journal of Medicine;2023-10-01

2. Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics;Journal of Clinical and Experimental Hematopathology;2023

3. IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers;CLIN PATHOL;2022

4. Mantle cell lymphoma and the evidence of an immature lymphoid component;Leukemia Research;2022-04

5. IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers;Clinical Pathology;2022-01